BRIDGE BIOTHERAPEUTICS INC.
Bridge Biotherapeutics, Inc. is a virtually-operated, venture-backed clinical stage global biotech company, headquartered in Seongnam, Korea with its subsidiary at JLABS@TMC, engaged in the development of novel therapeutics, focusing on therapeutic areas of high unmet medical needs, such as ulcerative colitis, fibrotic diseases, and cancers.
BRIDGE BIOTHERAPEUTICS INC.
Industry:
Biotechnology Medical
Founded:
2015-01-01
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.bridgebiorx.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
SPF Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Sectigo SSL Sectigo Domain SSL Korea Telecom
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Employees Featured
Stock Details
Company's stock symbol is KOSDAQ:288330
Official Site Inspections
http://www.bridgebiorx.com Semrush global rank: 4.56 M Semrush visits lastest month: 2.28 K
- Host name: 203.245.24.13
- IP address: 203.245.24.13
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
Loading ... 